# FILSPARI

NDC: 68974-200
Generic name: sparsentan
Labeler / Manufacturer: Travere Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230217

FDA application: NDA216403

## Active ingredients

- SPARSENTAN: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68974-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68974-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7354af1-f304-f4d9-e053-2995a90ab219